KRAS and colorectal cancer: In this study, we demonstrated that KRAS-mutant colorectal cancers were less sensitive to L-OHP and more sensitive to statins, and statins improved L-OHP hyposensitivity and cytotoxic effect in KRAS-mutated colorectal cancer cells.